Home » Topics » BioWorld Science

BioWorld Science
RSS

YTHDF1 is involved in renal fibrosis through upregulation of YAP

Feb. 16, 2022

Memo Therapeutics to advance lead programs

Feb. 16, 2022

NIBIOHN and Shionogi announce discovery of novel antiviral antibody for SARS-CoV-2

Feb. 16, 2022

Persistent Ebolavirus in brain seeds relapses

Feb. 16, 2022

NTS-104 reduces critical neuroinflammatory signaling in rat embolic stroke model

Feb. 16, 2022

Alamar and SciNeuro to discover and develop novel therapeutic antibodies for neurological diseases

Feb. 16, 2022

Aquinnah and Roche collaborate in ALS and neurodegenerative diseases

Feb. 16, 2022

Increasing catalase activity reverses estrogen-mediated aging

Feb. 16, 2022

ADAM8 drives severity in acute respiratory distress syndrome trough neutrophil migration

Feb. 16, 2022

Akouos presents preclinical data on anti-VEGF AAVAnc80 vector for vestibular schwannoma

Feb. 16, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...